What is the highest small-dense LDL particle number (sdLDL-P) that can be reported?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum sdLDL-P Reporting Limits

The provided evidence does not establish a specific maximum reportable value for small-dense LDL particle number (sdLDL-P), as this is a technical laboratory reporting limit rather than a clinical threshold addressed in cardiovascular guidelines.

What the Evidence Actually Addresses

The available guidelines and research focus on clinical risk thresholds and particle characteristics rather than laboratory reporting limits:

LDL Particle Number (Total LDL-P) Thresholds

  • High-risk threshold: >1600 nmol/L for total LDL-P 1
  • Studies report median values ranging from approximately 1400-1600 nmol/L in healthy populations 2
  • The highest quartile values in research cohorts reached levels around 1597 nmol/L or higher 2

Small-Dense LDL Characteristics

Small-dense LDL is defined by size ≤20.5 nm 1, 3, not by an absolute maximum particle count. The evidence shows:

  • sdLDL particles are more atherogenic due to reduced LDL receptor affinity, prolonged plasma residence time, greater oxidative susceptibility, and increased arterial proteoglycan affinity 3
  • Each standard deviation increment in small LDL particle number increases cardiovascular risk by 12% 4
  • sdLDL concentration is a significant ASCVD risk determinant independent of other lipid parameters 3

Laboratory-Specific Considerations

The maximum reportable sdLDL-P depends entirely on:

  • The specific analytical platform used (NMR spectroscopy is the primary method discussed 1, 2, 5)
  • Laboratory-specific validation and linearity studies
  • Instrument dynamic range and calibration limits

Key Technical Points

  • NMR spectroscopy measures both particle concentration and size 1, 2
  • Different platforms may have different upper limits of quantification
  • Corrections for particle geometry (spherical vs. disk vs. dimer forms) affect calculated values 5

Clinical Interpretation Guidance

Rather than focusing on a maximum value, clinical decision-making should prioritize:

  1. Total LDL-P >1600 nmol/L indicates high cardiovascular risk 1
  2. LDL size <20.5 nm defines small-dense phenotype (Pattern B) 1
  3. Discordance between LDL-C and LDL particle measures occurs frequently - in 57% of cases for LDL size/LDL-P comparisons 1

Contact your specific laboratory to determine their validated upper reporting limit for sdLDL-P, as this is a technical specification not standardized across platforms or addressed in clinical guidelines.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.